Epival and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported only by a few people who take Epival.

The study analyzes which people take Epival and have Common peroneal nerve dysfunction. It is created by eHealthMe based on reports of 968 people who have side effects while taking Epival from the FDA, and is updated regularly.

What is Epival?

Epival has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 1,088 Epival users. Check the latest studies of Epival.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,129 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

On Jul, 21, 2026

968 people reported to have side effects when taking Epival.
Among them, 4 people (0.41%) have Common peroneal nerve dysfunction.

Could Epival cause Common peroneal nerve dysfunction?

Among these 4 people:

What is the gender of people who have Common peroneal nerve dysfunction when taking Epival? *

female: 75 %
male: 25 %

What is the age of people who have Common peroneal nerve dysfunction when taking Epival? *

What are other drugs people take besides Epival? *

What are other side effects people have besides Common peroneal nerve dysfunction? *

Weakness: 3 people, 75.00%
Limb Discomfort (discomfort in leg): 3 people, 75.00%
Balance Disorder: 3 people, 75.00%
Burning Sensation: 3 people, 75.00%
Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 3 people, 75.00%
Chest Pain: 3 people, 75.00%
Crying: 3 people, 75.00%
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function): 3 people, 75.00%
Depression: 3 people, 75.00%
Discomfort: 3 people, 75.00%

What are the existing conditions these people have? *

Sleep Disorder: 3 people, 75.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 75.00%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 75.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 25.00%
Multiple Myeloma (cancer of the plasma cells): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Epival and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Epival:

Epival (1,088 reports)

Browse all side effects of Epival:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (651 drugs)

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (1,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium (the active ingredients of Epival) and Epival (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.